Wednesday, January 04, 2023 by: JD Heyes
Tags: badhealth, badmedicine, Big Pharma, booster shots, Censored Science, Collusion, conspiracy, covid boosters, covid vaccines, covid-19, Dangerous Medicine, immune suppression, immune system, Long-COVID, media fact watch, outbreak, pandemic, Pfizer vaccines, pharmaceutical fraud, research, spike protein, vaccine damage, vaccine injury, vaccine wars, vaccines
This article may contain statements that reflect the opinion of the author
22KVIEWS
(Natural News) If our country had an honest and competent ‘mainstream’ media staffed
with professionals who took to heart our founders’ intent of a free press to
hold those in power to account, there would be an outcry for one of the world’s
biggest pharmaceutical companies to be held responsible for the damage it did
to countless millions of people via faulty COVID-19 vaccines.
As reported by Conservative Review‘s Daniel
Horowitz, “Tolerance is a good
thing in most aspects of life. But when it comes to the immune system,
artificially juicing up the body to create antibodies with long-term tolerance
to a pathogen is a recipe for disaster.”
He noted
further:
Amid
thousands of papers on COVID and the vaccines, a new German paper published in Science Immunology should be the headline story this week. Although the subject
matter is very dense, the implication of it is that the Pfizer shots
(and possibly other mRNA spike protein shots) caused the immune system to
misfire, thereby creating an endless feedback loop of viral immune
escape, perpetuating the pandemic in the macro, and creating
immune suppression for the individuals who received them.
He went on to
write that it is “vexing” as to why, today, the virus remains with us,
questioning the fact that whereas so many countries in the Pacific Rim did well
against COVID in 2020 and 2021 but now have a much bigger problem in 2022 with
a less virulent strain. He asks further why it appears as though this pandemic
won’t end and so many people continue to contract it more than once.
“None of this
is normal,” he wrote. “Wherever you turn, the most vaccinated countries are not
only experiencing rampant side effects from the shots, but worse outcomes from
COVID itself following their endless booster campaigns.”
“Portugal is
the most vaccinated nation in all of Europe (95% vax’d, 70% boosted) and yet
just as many people are dying now as in 2021 and significantly more people than
in 2020 (when no one was vax’d and no one had immunity and covid was more
virulent). Safe and effective?” the Twitter account PLC noted, along with a
graphic chart showing a historic spike in mortality in the country.
Horowitz
notes further:
But even more
telling than an epidemiological comparison of one nation to another is a
comparison of outcomes within nations themselves between pre- and
post-vaccination/booster campaign. Prior to the mass vaccination, two parts of
the world largely escaped excess deaths from the virus: continental Africa and
the Pacific Rim nations. Yet whereas Africa flatlined in terms of
COVID deaths throughout 2021-2022, countries like Japan only experienced
meaningful numbers of deaths after the mass vaccination program.
The chart, Horowitz pointed out, shows that Japan’s COVID death curves are progressively worse, and that the change only began after most citizens, and seniors, in particular, were boosted, despite the fact that the Omicron variant is far less pathogenic than previous strains. He also noted that Japan currently leads the world in cases of coronavirus per million people while adding that Australia is experiencing a similar phenomenon.
Contrast these two high-boost nations with Nigeria, Africa’s most populous country and where few are vaccinated, Horowitz pointed out.
What’s going
on? Horowitz cites the German study:
A group of
German researchers tested for which specific antibody levels spike at what
time. Specifically, they tested the Pfizer shot against the AstraZeneca shot
and discovered something very concerning. Increasingly over time, and
particularly with three doses of Pfizer, the immune response switched from the
more neutralizing IgG1 and IgG3 antibodies to the non-neutralizing “tolerating”
IgG4 antibodies:
High levels
of neutralizing SARS-CoV-2-antibodies are an important
component of vaccine-induced immunity. Shortly after the initial two mRNA
vaccine doses, the IgG response mainly consists of the pro-inflammatory
subclasses IgG1 and IgG3. Here, we report that several months after the second
vaccination, SARS-CoV-2-specific antibodies were increasingly composed
of non-inflammatory IgG4, which were further boosted by a third
mRNA vaccination and/or SARS-CoV-2 variant breakthrough infections.
IgG4 antibodies among all spike-specific IgG antibodies rose on average from
0.04% shortly after the second vaccination to 19.27% late after the third
vaccination. This induction of IgG4 antibodies was not observed after
homologous or heterologous SARS-CoV-2 vaccination with adenoviral vectors
[emphasis added].
This is
important, he says, because — according to the study — “not only do these shots fail to produce the first
line of defense antibodies known
as IgA in the mucosal, something we knew from day one, but even the blood-based
antibodies are increasingly the wrong type. This problem seems to get worse
over time and with more doses of the shot, which correlates perfectly with
numerous studies showing negative efficacy increasing over time, with more
doses, and how the vaccinated take longer to clear the virus.”
This would
certainly explain two things: Why vaccinated and boosted individuals continue
to contract the virus more than once; and the presence of so-called “long COVID” symptoms.
Again, if we
had a responsible press and not a gaggle of statist propagandists, this
information would be leading the news cycle for weeks until someone, somewhere,
was held accountable.
Sources
include:
------
Class
switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated
SARS-CoV-2 mRNA vaccination
PASCAL IRRGANG HTTPS://ORCID.ORG/0000-0003-2829-6096, JULIANE GERLING HTTPS://ORCID.ORG/0000-0003-3528-7251, KATHARINA KOCHER HTTPS://ORCID.ORG/0000-0003-2331-3838, DENNIS LAPUENTE HTTPS://ORCID.ORG/0000-0002-9833-5313, PHILIPP STEININGER, KATHARINA HABENICHT, MONIKA WYTOPIL HTTPS://ORCID.ORG/0000-0002-4919-9773, STEPHANIE BEILEKE, SIMON SCHÄFER, [...], AND MATTHIAS TENBUSCH HTTPS://ORCID.ORG/0000-0003-3951-9056 +13 authorsAuthors Info &
Affiliations
SCIENCE IMMUNOLOGY
22 Dec 2022
First Release
DOI: 10.1126/sciimmunol.ade2798
Metrics
Total Downloads152.340
- Last 6 Months152.340
- Last 12 Months152.340
·
o
Abstract
o
RESULTS
·
CURRENT ISSUE
Abstract
RNA vaccines are efficient
preventive measures to combat the SARS-CoV-2 pandemic. High levels of
neutralizing SARS-CoV-2-antibodies are an important component of
vaccine-induced immunity. Shortly after the initial two mRNA vaccine doses, the
IgG response mainly consists of the pro-inflammatory subclasses IgG1 and IgG3.
Here, we report that several months after the second vaccination,
SARS-CoV-2-specific antibodies were increasingly composed of non-inflammatory
IgG4, which were further boosted by a third mRNA vaccination and/or SARS-CoV-2
variant breakthrough infections. IgG4 antibodies among all spike-specific IgG
antibodies rose on average from 0.04% shortly after the second vaccination to
19.27% late after the third vaccination. This induction of IgG4 antibodies was
not observed after homologous or heterologous SARS-CoV-2 vaccination with adenoviral
vectors. Single-cell sequencing and flow cytometry revealed substantial
frequencies of IgG4-switched B cells within the spike-binding memory B-cell
population (median 14.4%; interquartile range (IQR) 6.7–18.1%) compared to the
overall memory B-cell repertoire (median 1.3%; IQR 0.9–2.2%) after three
immunizations. Importantly, this class switch was associated with a reduced
capacity of the spike-specific antibodies to mediate antibody-dependent
cellular phagocytosis and complement deposition. Since Fc-mediated effector
functions are critical for antiviral immunity, these findings may have
consequences for the choice and timing of vaccination regimens using mRNA
vaccines, including future booster immunizations against SARS-CoV-2.
Bron: https://www.science.org/doi/10.1126/sciimmunol.ade2798
